Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

ACS Nano

Topics

Biology

Materials Science

Chemistry

Medicine

Biochemistry

Show all topics

DOI

10.1021/nn3044066

Other Formats

PDF